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Abstract
Background—Some of the genetic vulnerability for addiction may be mediated by impulsivity.
This study investigated relationships among impulsivity, substance use problems and six
neurexin-3 (NRXN3) polymorphisms. Neurexins (NRXNs) are presynaptic transmembrane
proteins that play a role in the development and function of synapses.
Methods—Impulsivity was assessed with the Barratt Impulsiveness Scale Version 11 (BIS-11),
the Boredom Proneness Scale (BPS) and the TIME paradigm; alcohol problems with the Michigan
Alcoholism Screening Test (MAST); drug problems with the Drug Abuse Screening Test
(DAST-20); and regular tobacco use with a single question. Participants (N = 439 Caucasians,
64.7% female) donated buccal cells for genotyping. Six NRXN3 polymorphisms were genotyped:
rs983795, rs11624704, rs917906, rs1004212, rs10146997 and rs8019381. A dual luciferase assay
was conducted to determine whether allelic variation at rs917906 regulated gene expression.
Results—In general, impulsivity was significantly higher in those who regularly used tobacco
and/or had alcohol or drug problems. In men, there were modest associations between rs11624704
and attentional impulsivity (p = .005) and between rs1004212 and alcohol problems (p = .009). In
women, there were weak associations between rs10146997 and TIME estimation (p = .03); and
between rs1004212 and drug problems (p = .03). The dual luciferase assay indicated that C and T
alleles of rs917906 did not differentially regulate gene expression in vitro.
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Conclusions—Associations between impulsivity, substance use problems and polymorphisms
in NRXN3 may be gender specific. Impulsivity is associated with substance use problems and may
provide a useful intermediate phenotype for addiction.
Keywords
NRXN3; cell adhesion protein; substance use disorder; impulsiveness
1. Introduction
There is abundant evidence that an individual’s vulnerability to addiction is influenced by
their genetic makeup but identifying the genes that contribute to that risk has been and
continues to be a vexing task (Li and Burmeister, 2009). For a given substance use disorder,
there is an expectation that there are genes that affect addiction vulnerability to that
particular substance, and that there are also genes that influence traits that increase
vulnerability to addiction, in general. For example, polymorphisms in genes that code for
enzymes involved in alcohol metabolism (i.e., alcohol dehydrogenase [ADH] and aldehyde
dehydrogenase [ALDH]) have been convincingly shown to influence risk for alcohol
dependence, and a gene that codes for an enzyme involved in catecholamine metabolism
(i.e., catechol-o-methyl transferase [COMT]) appears to influence addiction risk through its
influence on behavioral traits such as impulsivity and anxiety (Ducci and Goldman, 2008).
Impulsivity is an interesting trait in the context of addiction vulnerability. The general
construct of “impulsivity” represents several independent facets such as response inhibition,
resistance to delay of reinforcement, timing, behavioral switching, motor impulsivity,
cognitive impulsivity, preparation, execution outcome, premature responding and lack of
persistence (Evenden, 1999). Individuals with elevated levels of impulsivity are at increased
risk for problems with alcohol (Dick et al., 2009; Lejuez et al., 2010), stimulants (Ersche et
al., 2010), and nicotine (Doran et al., 2009; Spillane et al., 2010). In animal models,
individual differences in different facets of impulsivity predict drug self-administration and
exposure to drugs and increase impulsivity (see Winstanley et al., 2010 for a review). Slow
developing behavioral control in children is associated with increased risk for adolescent
substance use (Wong et al., 2006) and gender appears to modify the association between
different types of impulsivity and alcohol problems (Stoltenberg et al., 2008). The relations
among different facets of impulsivity and aspects of substance use or problems are not yet
fully characterized, but there is growing appreciation of their complexity (Lejuez et al.,
2010). There is some emerging evidence that individual differences in certain facets of
impulsivity are influenced by genes in neurotransmitter systems (e.g., Stoltenberg et al.,
2006; Walderhaug et al., 2010), but little is known about the underlying genetic architecture
of impulsivity.
Recent empirical evidence suggests that the gene that codes for Neurexin-3 (NRXN3) may
be a good candidate for general addiction vulnerability. Certain alleles of three single
nucleotide polymorphisms (SNPs) within the fifth splice site of the NRXN3 gene were more
common in alcohol dependent subjects than in matched controls (Hishimoto et al., 2007). A
genome wide association study found suggestive evidence that a NRXN3 SNP (rs2221299)
was associated with nicotine dependence (Bierut et al., 2007). Another NRXN3 SNP
(rs1004212) was associated with the amount of nicotine consumption in schizophrenia
patients (Novak et al., 2009). A genome-wide linkage study indicated an area on
chromosome 14q, on which the NRXN3 gene is located, was linked to opioid dependence
(Lachman et al., 2007).
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Neurexins (NRXNs) are presynaptic transmembrane proteins that function as cell adhesion
molecules, binding with neuroligins to stabilize the synapse (Hata and Südhof, 1995). There
is growing evidence that neurexins are key elements properly functioning synapses and that
NRXN dysfunction may play a role in diseases with a cognitive component (Südhof, 2008).
The genes that code for NRXNs are large, contain numerous polymorphisms and are subject
to alternative splicing. Regulatory region and splice site variants are likely to have a
substantial impact on NRXN expression. NRXN proteins are encoded by three separate,
unlinked genes: NRXN1 (2p16.3), NRXN2 (11q13), and NRXN3 (14q31). Each of the three
NRXN genes has two promoters from which a longer alpha and shorter beta NRXNs are
transcribed (Rowen et al., 2002). The alpha promoters are located at the 5′ end of the genes,
while the beta promoters are located between exons 17 and 18 (Rowen et al., 2002). Each of
these NRXN genes also has multiple alternative splice sites and thousands of possible
isoforms (Tabuchi and Südhof, 2002). The NRXN3 gene is one of the largest genes in the
human genome containing 1,826,818 base pairs (Rowen et al., 2002).
Lines of mice with the α-NRXN gene knocked out showed that α-NRXN is responsible for
the coupling of Ca2+-channels to synaptic vesicles in preparation for exocytosis, and that
they are essential for normal neurotransmitter release (Missler et al., 2003). These α-NRXN
knockout mice had low survival rates, and those that did survive had decreased
neurotransmitter release at both inhibitory (gamma-amino butyric acid; GABA) and
excitatory (glutamate) synapses. GABA is the brain’s major inhibitory neurotransmitter, and
alcohol had been shown to mimic its effects on the GABAA receptor (Lovinger and
Homanics, 2007). During development, α-NRXNs on pre-synaptic neurons promote post-
synaptic specialization of GABAergic neurons by clustering GABAA receptors (Kang et al.,
2007). The involvement of NRXNs in normal neurotransmitter release and synaptic integrity
suggests that variation in their genes may have widespread and substantial effects on key
behavioral phenotypes such as impulsivity. To our knowledge, there have been no studies to
date to examine potential associations between NRXN3 polymorphisms and impulsivity.
This study was designed to investigate potential associations among types of impulsivity,
substance use problems, and genetic polymorphisms in NRXN3. Our hypothesis is in line
with the notion that impulsivity is a key construct in the pathways from genes to risky
behaviors, which can lead to behavioral disorders such as addiction.
2. Methods
2.1. Identifying Single Nucleotide Polymorphisms for Genotyping
The SNP@Promoter database was used to identify SNPs in the NRXN3 α-promoter that may
affect gene regulation (http://variome.kobic.re.kr/SNPatPromoter/; Kim et al., 2008). We
identified 20 SNPs found within the α-promoter, and selected one of these SNPs (rs917906;
chromosome 14 position 77,939,227) because of its location in a transcription factor (TF)
binding site [the CCAAT/ Enhancer Binding Protein-gamma (C/EBPγ)] 619 base pairs
upstream of the start codon. Though termed “enhancer” the C/EBPγ TF can act as both an
activator and repressor depending on the cell and promoter context (Parkin et al., 2002).
Recently, a report was published that identified several areas in putative regulatory regions
upstream of the NRXN3 structural gene (Pedrosa et al., 2010). Using HapMap, we identified
21 SNPs located in those regions and then used SNP Cutter software (Liu et al, 2009), to
identify two (rs983795, position 77,767,309 and rs11624704, position 77,855,830) for
which we could design restriction fragment length polymorphism assays.
We also genotyped three other SNPs, using TaqMan SNP Genotyping Assays because they
were previously identified as being associated with alcohol dependence (rs8019381, position
Stoltenberg et al. Page 3
Drug Alcohol Depend. Author manuscript; available in PMC 2012 December 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
79,390,336; Hishimoto et al. 2007), quantity of nicotine intake (rs1004212 position
78,250,979; Novak et al., 2009) and obesity (rs10146997, position 79,014,915; Heard-Costa
et al., 2009).
2.2 Participants and Measures
All participants were recruited at a small Midwestern university via posters and in-class
presentations about the study, were informed about the particular study and signed informed
consent documents. Participants (N = 477) completed multiple questionnaires that assessed
impulsivity and involvement in health-risk behaviors, four computer tasks, and donated
buccal cells for genotyping. Participation in this study was voluntary, and all participants
were compensated $20. The study was approved by the Institutional Review Board (IRB). In
this manuscript we will report only analyses focused on testing the associations between
impulsivity, NRXN3 polymorphisms, and substance use problems; other findings from this
study will be reported elsewhere.
To reduce the risk of population stratification data was analyzed from only the 92% who
self-identified as Caucasians (N = 439; 64.7% female). Age ranged from 18 to 67 (Mean=
22.49, SD= 6.12; 81.6% were age 24 or younger). Four individuals did not report age.
The Barratt Impulsiveness Scale (BIS-11) is a 30-item self-report instrument that uses a 4-
point Likert scale from Rarely/Never to Almost Always (Patton et al., 1995). A total score is
calculated by summing three subscale scores. The subscales are: Motor (“I act on the spur of
the moment”), Attentional (“I have outside thoughts when thinking”) and Nonplanning (“I
plan trips well ahead of time” reverse scored). The total score is reliable (in terms of internal
consistency, Cronbach’s α = .86 in this study).
The Boredom Proneness Scale (BPS) is a 28-item self-report instrument that uses a 5-point
Likert scale from “highly disagree” to “highly agree” (Farmer and Sundberg, 1986). A total
score is calculated by summing five subscales. The subscales include: External Stimulation
(“When I was young, I was often in monotonous and tiresome situations”), Internal
Stimulation (“It is easy for me to concentrate on my activities” reverse scored), Affect
(“Frequently when I am working I find myself worrying about other things”), Time
Perception (“Time always seems to be passing slowly”) and Constraint (“I am good at
waiting patiently” reverse scored). The total score has good reliability (Cronbach’s α = .86
in this study).
The The Time Paradigm (Dougherty et al., 2005) was administered on a desk top personal
computer with a cathode ray tube display with a refresh rate of 60 Hz. The Time Paradigm is
a behavioral assessment of the passage of time. Participants were asked to estimate the
passage of 60 s five times. Participants were instructed to press the space bar to start the
timer and to press it again when they thought that 60 s had passed. We analyzed the mean of
the five estimates. Participants did not receive any feedback regarding the accuracy of their
estimates or any payments based on their performance.
We assessed tobacco use with a single yes/no item: “Do you regularly use tobacco
(cigarettes, cigars, chewing tobacco)?” We assessed alcohol problems with 22 items from
the Michigan Alcohol Screening Test (MAST; Selzer, 1971). It consists of yes or no
questions about alcohol consumption and related behaviors that were scored as either 1 (yes)
or 0 (no), and are summed for a total score. We assessed drug problems with the Drug
Abuse Screening Test (DAST-20), which is a 20 item self-report questionnaire that
measures an individual’s involvement with drugs (not alcohol or tobacco) over the
preceding 12 months (Skinner, 1982). Responses to the items were scored as either 1 (yes)
or 0 (no), and are summed for a total score. For both the MAST and the DAST we used a
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cutoff score of five to identify those with probable problems (i.e., 0-5 = no problems, 6+ =
problems).
2.3. Genotyping
DNA was extracted using the DNeasy Blood and Tissue Kit (Qiagen Inc, Valencia, CA,
USA). Twenty μL PCR reactions for rs8019381 (Applied Biosystems, Inc., genotyping
assay ID, C_29283249_10), rs917906 (C_2674044_20), rs1004212 (C_16183691_10) and
rs10146997 (C_30288512_10), were prepared in 2x ABI TaqMan Universal Master Mix no
UNG (Applied Biosystems, Inc., Foster City, CA) adding the corresponding 20x Taqman
SNP genotyping assay containing Fam and Vic-labelled allele-specific TaqMan MGB
probes and forward and reverse primers. The PCR was performed with the following cycling
parameters: 95°C for 10 min, followed by 40 cycles of 92°C for 15 sec and 60°C for 1 min.
End point FAM and VIC florescence levels were measured StepOnePlus Real-Time PCR
System (Applied Biosystems, Inc., Foster City, CA), and genotype calls were made based on
this level of fluorescence signal.
rs983795 was amplified using the primers: forward: 5′-AGG GAT ACC TGT TGG GAG
AAC C-3′ and reverse: 5′-TTA GAG CCAA GGC ACT ACA CCC-3′. PCR reactions
(25μL) contained 20ng of DNA, 1X GoTaq Green Master Mix (Promega), and 400nM final
concentration of each primer. The PCR was performed with the following cycling
parameters: 95°C for 6 min, followed by 35 cycles of 95°C for 30 sec, 56.6°C for 30 sec,
and 72°C for 1 min, with a final extension at 72°C for 10 min. Ten μL of the PCR product
was digested for 1 hour at 37°C with 20 units of NdeI enzyme (New England Biolabs) and
run on a 1% agarose gel at 100V for 1.5 hours. Fragments were visualized under UV light
with ethidium bromide stain. Fragment sizes for alternative alleles are A= 373bp and G=
259bp and 114bp.
rs11624704 was amplified using the primers: forward: 5′-TTG CCT TAC ACA CTG GTG
GTT G-3′ and reverse: 5′-AAT GCA CTT CTG TTC CTC CAG C-3′. PCR reactions (25μL)
contained 20ng of DNA, 1X GoTaq Green Master Mix (Promega), and 400nM final
concentration of each primer. The PCR was performed with the following cycling
parameters: 95°C for 6 min, followed by 35 cycles of 95°C for 30 sec, 55.8°C for 30 sec,
and 72°C for 1 min, with a final extension at 72°C for 10 min. Ten μL of the PCR product
was digested for 1 hour 37°C with 2.5 units of MseI enzyme (New England Biolabs) and run
on a 1% agarose gel at 100V for 1.5 hours. Fragments were visualized under UV light with
ethidium bromide stain. Fragment sizes for alternative alleles are C= 276bp and A= 135bp
and 141bp.
Genotyping assays were repeated for approximately 10% of samples for all six SNPs. There
were no discrepancies among genotype calls.
2.4. Dual Luciferase Assay
To determine whether allelic variation at the rs917906 affected gene expression, a dual
luciferase assay was conducted by amplifying the 301bp region from two individual DNA
samples (one with a C/C genotype and one with a T/T genotype for the rs917906) as
described above with the exception of the final extension being extended to 30 minutes; to
ensure addition of the 3′ terminal A by Taq polymerase for use in the T-A cloning. The
resulting amplicons were cloned into the TOPO-TA vector (Invitrogen, Carlsbad, CA,
USA). Inserts were excised with XhoI and HindIII enzymes to generate constructs in the
forward orientation, and cloned into the pGL4.1 vector (Promega, Madison, WI, USA). The
constructs were verified by sequencing.
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The RN46A raphe-derived neuronal cell line was provided by Scott R. Whittemore
(University of Louisville School of Medicine). Cells were cultured in Dulbecco’s Modified
Eagles Medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS) 100 units/mL
of penicillin, 100μg/mL of streptomycin, and 250μg/mL G418. Cell culture medium without
antibodies included on the DMEM and 10% FBS. RN46A cells were cultured at 33°C in a
humidified 5% CO2 atmosphere for two days. The medium was then changed to cell culture
medium without antibodies for two days. The transfection then began on the fifth day.
Two clones of each genotype (C/C and T/T) were used. RN46A cells were transfected with
1μg of the rs917906 reporter constructs plus 0.1μg of the Renilla luciferase pRL-SV40
control DNA using Lipofectamine 2000 and incubated for twenty minutes at room
temperature. After incubation, 150μL was added to each well which contained the RN46A
raphe neurons and medium. The plate was then gently mixed by rocking back and forth, then
incubated at 33°C in a humidified 5% CO2 atmosphere for 24 hours. Luciferase activity was
then assayed using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI,
USA) according to the manufacturer’s instructions. Luciferase activity was normalized
relative to the activity of the Renilla luciferase produced by the pRL-SV40 control vector
and each construct was tested in three independent experiments.
2.5. Statistical Analyses
Multivariate general linear models were used to test associations between impulsivity
subscale scores, gender and substance use problems (IBM, SPSS Statistics, 19; Chicago IL).
To test associations between NRXN3 SNPs and impulsivity and substance use problems
separately for men and women we used basic allele tests in SNP and Variation Suite 7
(Golden Helix, Bozeman MT). In basic allele tests for a given phenotype, individuals are
considered to have two identical phenotype scores, one for each allele. That is, each element
in an individual’s genotype is considered to correspond to the same phenotypic value. Basic
allele tests do not enable testing of additive or dominance models. We chose to conduct
basic allele tests rather than examining additive and dominance models to reduce the number
of comparisons thereby preserving statistical power. A paired t-test was conducted for the
dual luciferase reporter assay to determine whether rs917906 alleles differentially affected
transcription.
3. Results
3.1. Descriptive Statistics
Overall descriptive statistics are shown in Table 1. Our sample of men and women did not
differ significantly by age. However, men had higher mean scores on Time estimation (p = .
038), BIS-11 Total (p = .01), and Motor subscale (p = .001), BPS Total (p = .016) and
External Stimulation subscale (p = .000). The percent reporting regular use of tobacco did
not differ for men and women. There was a trend for more men to be classified as having
alcohol problems (p = .092). More men than women were classified as having drug
problems (p = .018). Subsequent analyses of behavioral data were conducted separately for
men and women in order to reduce potential confounds and to preserve our capacity to
detect differences in patterns of association.
Marker statistics for the six NRXN3 SNPs tested are shown in Table 2. Genotype
frequencies are shown in Table 3. All markers, but rs917906 were in Hardy-Weinberg
equilibrium (p>.05). We genotyped rs917906 using the TaqMan assay and an RFLP method
and neither method resulted in genotype calls that were in HW equilibrium. We were unable
to determine the cause of this discrepancy and although we are confident with our genotype
calls, we acknowledge that the lack of HW equilibrium with this marker should be
Stoltenberg et al. Page 6
Drug Alcohol Depend. Author manuscript; available in PMC 2012 December 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
considered in interpretation. There were no linkage disquilibrium (LD) blocks in our sample
or in the combined panel of Utah residents with Northern and Western European ancestry
from the CEPH collection and Toscans in Italy (CEU+TSI) sample of HapMap data (see
Figure 1). The pattern of LD that we observed in our sample was similar to that seen in the
CEU+TSI sample.
3.2. Impulsivity and Regular Tobacco Use
For men who indicated regular tobacco use, multivariate general linear models with age as a
covariate indicated significantly higher mean scores for the Attentional (p = .005),
Nonplanning (p = .000) and Motor (p = .001) subscales of the BIS-11 and for the Perception
of time (p = .031) subscale of the BPS (see Figure 2). For women who indicated regular
tobacco use, multivariate general linear models with age as a covariate indicated
significantly higher mean scores for the Attentional (p = .01), Nonplanning (p = .001) and
Motor (p = .001) subscales of the BIS-11 and for the External stimulation (p = .033), Affect
(p = .004), Perception of time (p = .028), and Constraint (p = .006) subscales of the BPS.
Time estimation was not significantly associated with tobacco use in men or women.
3.3. Impulsivity and Alcohol Problems
For men who had alcohol problems (i.e., MAST > 5), multivariate general linear models
with age as a covariate indicated significantly higher mean scores for the Attentional (p = .
018), Nonplanning (p = .000) and Motor (p = .000) subscales of the BIS-11 (see Figure 3).
None of the mean BPS subscale scores were different for men with and without alcohol
problems. For women who had alcohol problems, multivariate general linear models with
age as a covariate indicated significantly higher mean scores for the Attentional (p = .005),
Nonplanning (p = .011) and Motor (p = .000) subscales of the BIS-11 and for the External
stimulation (p = .028), Affect (p = .007), Perception of time (p = .000), and Constraint (p = .
035) subscales of the BPS. Time estimation was not significantly associated with alcohol
problems in men or women.
3.4. Impulsivity and Drug Problems
For men who had drug problems (i.e., DAST > 5), multivariate general linear models with
age as a covariate indicated significantly higher mean scores for the Nonplanning (p = .002)
and Motor (p = .000) subscales of the BIS-11 (see Figure 4). None of the mean BPS
subscale scores were different for men with and without drug problems. For women who
had drug problems, multivariate general linear models with age as a covariate indicated
significantly higher mean scores for the Attentional (p = .000), Nonplanning (p = .000) and
Motor (p = .000) subscales of the BIS-11 and for the Perception of time (p = .006), subscale
of the BPS. Time estimation was not significantly associated with drug problems in men or
women.
3.5. NRXN3 Association Tests
Basic allele tests identified a significant association between rs11624704 and BIS-11 Total
Score (p = .01; see Table 4). Although this result does not survive Bonferroni correction
(i.e., for each phenotype we conducted six independent association tests for each gender;
pcrit = .05/6 = .008), it suggests that investigating potential associations between rs11624704
genotype and BIS-11 subscales might identify one or more subscales to be associated with
the SNP. Therefore, we then conducted basic allele tests of rs11624704 on the three BIS-11
subscales in men, which indicated a significant association with Attentional impulsivity (p
= .005; Bonferroni correction pcrit = .05/3 = .017; see Figure 5). In women, there was
evidence of a weak association between Time Estimation and rs10146997 genotype (p = .
027) that fails to survive Bonferroni correction (pcrit = .05/6 = .008).
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Basic allele tests identified a significant association between rs1004212 and alcohol
problems in men (p = .009; see Table 4 and Figure 4). Having a copy of the T allele of
rs1004212 increased risk for having alcohol problems 2.54 times. Interestingly, in women
the same allele decreased risk for having drug problems (p = .03; OR = 0.29). Although
neither of these findings survived strict Bonferroni correction, they suggest that further study
of this locus is needed.
3.6. Luciferase Reporter Assay
To determine whether alternative alleles at rs917906 regulate gene expression of the
luciferase gene in vitro, a ratio of the expression of the luciferase over the expression of the
control Renilla luciferase was calculated. Using this ratio a paired t-test was performed. No
significant difference was found between the C (Mean expression= 0.0481) and T (Mean
expression= 0.0480) alleles: paired t(5) = 0.027, p= 0.97. Therefore, the C and T alleles do
not differentially regulate NRXN3 transcription in vitro.
4. Discussion
We found suggestive evidence that NRXN3 polymorphisms are associated with impulsivity
(i.e., rs11624704 and Attentional impulsivity) and alcohol problems (rs1004212) in men. To
our knowledge, this is the first report of an association between a NRXN3 polymorphism and
impulsivity. This finding may prove to be important in understanding the genetic
architecture of addiction because impulsivity is an important risk factor for addictions and
other behavioral disorders. Evidence is accumulating that NRXN3 may be in a pathway that
influences vulnerability to addiction in general. In that sense, our findings add to the
growing evidence that implicates polymorphism in NRXN3 in risk for substance use
problems and/or dependence (Lachman et al., 2007; Hishimoto et al., 2007; Beirut et al.,
2007) and obesity (Heard-Costa et al., 2009). We recognize that the overlap in genetic risk
for addiction to different substances and obesity is likely to be quite narrow, but it may be
that this overlap includes genetic polymorphisms associated with individual differences in
impulsivity. Further investigation with detailed phenotypic assessment that includes patterns
of substance use, substance use disorder diagnoses, multiple measures of impulsivity and
additional NRXN3 polymorphisms should be conducted.
Novak et al. (2009) reported that in individuals with schizophrenia those with the C/C
genotype of rs1004212 smoked more cigarettes per day on average than those with the C/T
genotype. We did not find an association between rs1004212 genotype and regular tobacco
use, which is consistent with Novak et al. (2009), who did not find an association with
rs1004212 and risk for smoking. We did not assess the quantity of tobacco used for those
who reported to be regular tobacco users in our study, so we cannot directly test the
previously reported association. Our primary finding with substance use problems, however,
was that in men, rs1004212 genotype was associated with risk for alcohol problems. We
found that men carrying a T allele were at 2.54 times greater risk of having alcohol problems
than C/C homozygotes. Interestingly, in women, there is a non-significant trend for the T
allele to be associated with reduced risk of having a drug problem by about one third (OR =
0.39). Taken together, these findings suggest that rs1004212 should continue to be a SNP of
interest in the context of addiction vulnerability.
Our finding that rs11624704 genotype was associated with a specific facet of impulsivity
(BIS-11 Attentional) in men, but not in women, suggests that the influence of NRXN3
polymorphisms may be rather specific and that the use of composite scores or other
somewhat gross measures and/or statistically controlling for gender differences may fail to
identify potentially interesting associations. At this time, we have no explanation for gender
specific effects of NRXN3.
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We found strong evidence that higher impulsivity is associated with regular tobacco use and
problems with alcohol and drugs. Mean subscale scores from the Barratt Impulsiveness
Scale (version 11) were significantly higher for both men and women for regular tobacco
users, and for those with alcohol and drug problems with the only exception being
Attentional impulsivity in men with drug problems. In this single case, those men with drug
problems had higher mean scores than those without, but the difference did not reach
significance (p = .17). The Barratt Impulsiveness Scale appears to assess facets of
impulsivity that are relevant to addiction similarly in men and women. We observed less
consistent patterns with the Boredom Proneness Scale subscales. When there were
significant differences between those who used tobacco or had problems with alcohol or
drugs, the substance using group had a higher mean score than the comparison group. In
men, the mean BPS subscale scores were not different for those with and without substance
use problems. Only the perception of time subscale differed for men grouped by regular
tobacco use. The BIS-11 appears to better assess substance use relevant aspects of
impulsivity. Mean scores for Time estimation were not significantly different for men or
women grouped by substance use/problem. However, it should be pointed out that the
direction of the effects, while not statistically different, were consistently in the expected
direction (i.e., shorter time estimates for substance use/problem groups). We think that
behavioral impulsivity measures show promise and we will continue to optimize their
parameters (e.g., number of trials and number of seconds estimated) for use in future studies.
Dick et al. (2009) present a compelling case that the construct of impulsivity may be best
studied by examining its many subfacets. In the present study, we used the well-known
BIS-11 subscales to examine Negative Urgency (BIS-11 Attentional), Lack of Planning (all
three BIS-11 subscales) and the less well known BPS to examine Lack of Perseverance
(boredom proneness). We also used the TIME paradigm to assess Judgment of Time Elapse
(see Tables 1 and 2 in Dick et al., 2009 for a discussion of how these measures assess
particular impulsivity subfacets). More work to characterize the pattern of association
between different subfacets of impulsivity and substance use phenotypes is needed.
Men are consistently found to be more likely than women to have drinking problems
(Wilsnack et al., 2000), and generally have more risk factors for alcohol use and problems
than women (Nolen-Hoeksema and Hilt, 2006). There is less consistency in findings relating
to differences in types of impulsivity based on gender (Reynolds et al., 2006). It does appear
however, that higher levels of impulsivity in men, partially mediates their increased risk for
alcohol problems (Stoltenberg et al., 2008). The present study appears to be the first report
of gender differences in patterns of association with the NRXN3 gene and behavior.
Alternative alleles at rs917906 did not differentially regulate gene expression in vitro. It is
possible that rs917906 exerts some regulatory control over NRXN3 expression, but in our
hands, the dual luciferase assay did not indicate differential expression. It may be that in
vivo rs917906 affects gene regulation in conjunction with other SNPs (i.e., a haplotype)
(Glatt et al., 2006), or that it is in linkage disequilibrium (LD) with a functional variant.
Another possibility for not observing a difference in transcriptional activity in the dual
luciferase assay is that because there are low levels of expression of C/EBPγ in the brain
(Kuo et al., 1990) it may not be expressed in raphe neurons or if it is expressed it may be at
very low levels. GABAergic Purkinje cells in the cerebellum have higher levels of C/EBPγ
expression than cells in other brain areas (Kuo et al., 1990). Given that NRXN proteins have
been found to be essential for normal release of neurotransmitters at GABA neurons
(Missler et al., 2003) it would be interesting to better characterize the regulatory impact of
rs917906 using Purkinje cells and the SHSY57 neuroblastoma cell line used by Pedrosa et
al. (2010). Additional NRXN3 regulatory region polymorphisms should also be tested for
potential transcriptional regulation.
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We recognize that our study has certain limitations and needs to be interpreted with some
caution. More detailed assessments of the potential associations between important addiction
related phenotypes (e.g., maximum number of drinks, age of onset) and genetic variation
across NRXN3 need to be conducted. In addition, other facets of impulsivity such as delayed
discounting need to be examined for association with NRXN3 polymorphisms. By current
standards, our sample size is considered rather small and the p-values we report are not
corrected for multiple comparisons, although we attempted to limit the number of
comparisons that we made in order to conserve statistical power. In our study sample, the
mean scores for the BIS-11 Total were higher than reported norms for both men and women
(Patton and Barratt, 1995). We do not have a ready explanation for this observation, but note
that more than a decade separates the two studies. It should be noted that our definitions of
alcohol and drug problems were not meant as a diagnosis of alcohol abuse or dependence,
but were used as a convenient metric of problematic substance involvement. Subsequent
studies to investigate the role of NRXN3 in substance use and problems should employ more
sensitive measures.
Our findings suggest that NRXN3 polymorphisms are modestly associated with specific
types of impulsivity and substance use problems and that these patterns of association are
not the same in men and women. Findings such as these, given their limitations, will be
critical as we continue to improve our understanding of the pathways from genes to
behavior. Impulsivity increases risk for several behavioral disorders such as addictions and
therefore is an outstanding candidate trait for further study. A more complete description of
the genetic architecture of impulsivity is likely to have a substantial impact on our
understanding of the genetic architecture of a variety of behavioral disorders. NRXN3 is a
promising candidate gene for addiction vulnerability and merits further study.
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Figure 1.
Linkage disequilibrium (LD) data (D’/LOD) for the six NRXN3 SNPs tested. A) The relative
location of the two alternatively spliced forms of NRXN3. B) LD data from CEU+TSI
samples from HapMap (version 3 release R2). C) LD data from this study.
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Figure 2.
Mean scores on impulsivity subscales for men and women who reported regularly using
tobacco. A) Barratt Impulsiveness Scale (version 11). B) Boredom Proneness Scale. *p<.05;
**p<.01; ***p<.001
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Figure 3.
Mean scores on impulsivity subscales for men and women who had alcohol problems (i.e.,
scoring 6 or more on the Michigan Alcoholism Screening Test). A) Barratt Impulsiveness
Scale (version 11). B) Boredom Proneness Scale. *p<.05; **p<.01; ***p<.001
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Figure 4.
Mean scores on impulsivity subscales for men and women who had drug problems (i.e.,
scoring 6 or more on the Drug Abuse Screening Test). A) Barratt Impulsiveness Scale
(version 11). B) Boredom Proneness Scale. *p<.05; **p<.01; ***p<.001
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Figure 5.
Significant associations between NRXN3 SNPs and behaviors. A) Mean (±s.e.) BIS-11
Attentional score for men and women grouped by rs11624704 genotype. B) Proportion
(95% CI) of individuals with alcohol problems in groups defined by rs1004212 genotype
and gender. P-values shown are not corrected for multiple comparisons.
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Table 1
Overall Descriptive Statistics; Mean (S. D.)
Men (n=155) Women (N=283) p-value
Age 22.53 (6.28) 22.46 (6.05) 0.910
Time Estimation 63.59 (18.22) 59.79 (18.28) 0.038
BIS-11
Total 66.83 (10.64) 63.96 (11.36) 0.010
Attentional 18.07 (4.10) 17.31 (4.14) 0.066
Nonplanning 24.75 (5.03) 24.10 (5.00) 0.197
Motor 24.01 (4.37) 22.55 (4.68) 0.001
BPS
Total 74.03 (11.03) 71.13 (12.43) 0.016
External Stimulation 22.94 (4.82) 20.28 (4.85) 0.000
Internal Stimulation 19.11 (4.78) 19.56 (4.63) 0.336
Affect 13.84 (2.99) 13.93 (3.12) 0.769
Perception of time 9.83 (2.91) 9.32 (2.84) 0.072
Constraint 5.83 (2.04) 5.78 (2.08) 0.838
Tobacco Use (%) 24.5 19.4 0.207
Alcohol Problem (%) 16.1 10.6 0.092
Drug Problem (%) 16.8 9.2 0.018
Note: Three men did not report age and one woman did not have scores for BPS. P-values are either from independent sample t-tests or chi-square
tests.
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Table 3
Genotype Frequencies by Gender
SNP Genotype Men
(n = 155)
Women
(n = 284)
Overall
(N = 439)
rs983795 A/A 0 8 8
A/G 37 71 108
G/G 118 205 323
rs11624704 C/C 3 3 6
C/A 30 75 105
A/A 118 205 323
rs917906 C/C 29 56 85
C/T 92 147 239
T/T 31 79 110
rs1004212 T/T 1 7 8
T/C 54 79 133
C/C 98 197 295
rs10146997 G/G 9 21 30
G/A 49 98 147
A/A 93 162 255
rs8019381 T/T 4 4 8
T/C 24 50 74
C/C 127 229 356
Note: All call rates >98%.
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